Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|September 30, 2016
Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPROMaryam Derogar, Hanna Dahlstrand, Stefan Carlsson, et al.Gynecologic Oncology|October 9, 2020
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancerSara Corvigno, Artur Mezheyeuski, Laura Martin De La Fuente, et al.The Journal of Pathology. Clinical Research|August 4, 2017
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarkerSara Corvigno, Magnus Frödin, G Bea A Wisman, et al.Gynecologic Oncology|February 6, 2025
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell densitySara Corvigno, Josefin Fernebro, Josefin Severin Karlsson, et al.International Journal of Cancer|March 31, 2009
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?Anders Näsman, Per Attner, Lalle Hammarstedt, et al.EMBO Molecular Medicine|March 3, 2020
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancerLidia Moyano-Galceran, Elina A Pietilä, S Pauliina Turunen, et al.Translational Oncology|March 20, 2026
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohortMaj K Kjeldsen, Frederik Otzen Bagger, Henrik Roed, et al.Nature Biomedical Engineering|April 25, 2019
Publisher Correction: Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneityNobuyuki Tanaka, Shigeaki Kanatani, Raju Tomer, et al.Nature Biomedical Engineering|April 25, 2019
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneityNobuyuki Tanaka, Shigeaki Kanatani, Raju Tomer, et al.Cancer Research Communications|November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerMaj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.Pageof 4